How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Abstract Myelodysplastic neoplasms, formerly known as myelodysplastic syndromes (MDS), represent a group of clonal disorders characterized by a high degree of clinical and molecular heterogeneity, and an invariable tendency to progress to acute myeloid leukemia. MDS typically present in the elderly...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAABRON PRESS
2022-12-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://doi.org/10.1007/s44228-022-00024-4 |